Ciclosporin does not influence bone marrow-Derived cell differentiation to myofibroblasts early after renal ischemia/reperfusion

American Journal of Nephrology

Volumn 30, Issue 1, 2009, Pages 73-83

  Broekema, Martine ^a   Harmsen, Martin C ^a   Koerts, Jasper A ^a   Van Kooten, Theo G ^a   Uges, Donald R A ^b   Petersen, Arjen H ^a   Van Luyn, Marja J A ^a   Navis, Gerjan ^a   Popa, Eliane R ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Biomedical Engineering ^*  (Netherlands)

Author keywords

Immunosuppression; Renal failure; Renal interstitial fibrosis; Stem progenitor cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 3; CYCLOSPORIN A; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; FISCHER 344 RAT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FIBROSIS; KIDNEY ISCHEMIA; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TRANSGENIC RAT; TREATMENT DURATION;

ACTINS; ANIMALS; BONE MARROW; CELL DIFFERENTIATION; CYCLOSPORINE; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; ISCHEMIA; KIDNEY; MALE; MUSCLE, SMOOTH; RATS; RATS, INBRED F344; REPERFUSION INJURY; STEM CELLS;

EID: 59749097423     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000202633     Document Type: Article

References (20)

1. Merville P: Combating chronic renal allograft dysfunction: optimal immunosup-pressive regimens. Drugs 20 05;65:615-631.
2. Andoh TF, Burdmann EA, Bennett WM: Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations. Semin Nephrol 1997;17:34-45.
3. Calne RY, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Pentlow BD, Rolles K: Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978;ii:1323-1327.
4. de Mattos AM, Olyaei AJ, Bennett WM: Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 2000;35:333-346.
5. Gabbiani G: The biology of the myofibro-blast. Kidney Int 1992;41:530-532.
6. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL: Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Tra nsplantation 1997;64:190-197.
7. Williams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R: Characterization of renal ischemia-reperfusion injury in rats. J Pharmacol Toxicol Methods 1997;37:1-7.
8. Broekema M, Harmsen MC, van Luyn MJ, Koerts JA, Petersen AH, van Kooten TG, van Goor H, Navis G, Popa ER: Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reper-fusion in rats. J Am Soc Nephrol 2007;18:165-175.
9. Kisseberth WC, Brettingen NT, Lohse JK, Sandgren EP: Ubiquitous expression of marker transgenes in mice and rats. Dev Biol 1999;214:128-138.
10. Kunter U, Floege J, von Jurgensonn AS, Stojanovic T, Merkel S, Grone HJ, Ferran C: Expression of A20 in the vessel wall of rat-kidney allografts correlates with protection from transplant arteriosclerosis. Transplantation 2003;75:3-9.
11. Keppler A, Gretz N, Schmidt R, Kloetzer HM, Groene HJ, Lelongt B, Meyer M, Sadick M, Pill J: Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay. Kidney Int 2007;71:74-78.
12. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
13. Broekema M, Harmsen MC, Koerts JA, Petersen AH, van Luyn MJ, Navis G, Popa ER: Determinants of tubular bone marrow-derived cell engraftment after renal ischemia/ reperfusion in rats. Kidney Int 2005;68:2572-2581.
14. Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG: Bone marrow stem cells contribute to repair of the isch-emically injured renal tubule. J Clin Invest 2003;112:42-49.
15. Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ, Igarashi P: Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003;14:1188-1199.
16. Lin F, Moran A, Igarashi P: Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 2005;115:1756-1764.
17. Broekema M, Harmsen MC, Koerts JA, van Kooten TG, Navis G, van Luyn MJ, Popa ER: Tubular engraftment and myofibroblast differentiation of recipient-derived cells after experimental kidney transplantation. Transplantation 2007;84:1003-1011.
18. Khanna A, Kapur S, Sharma V, Li B, Suthanthiran M: In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine. Transplantation 19 97;63:1037-1039.
19. Shin GT, Khanna A, Sharma VK, Ding R, Azizlerli S, Li B, Suthanthiran M: In vivo hy-perexpression of transforming growth factor-beta 1 in humans: stimulation by cyclosporine. Transplant Proc 1997;29:284.
20. Wolf G, Killen PD, Neilson EG: Cyclosporin A stimulates transcription and procollagen secretion in tubulointerstitial fibroblasts and proximal tubular cel ls. J Am Soc Nephrol 1990;1:918-922.